Analyze Diet

Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively.

Abstract: To determine changes in clinical signs of disease and response to pulmonary function testing in horses with recurrent airway obstruction (heaves) after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Methods: 6 horses with inducible and reversible heaves. Methods: Episodes of heaves were induced by exposure (challenge) to moldy hay and straw for 7 days. Horses were assigned to treatment groups (aerosolized beclomethasone dipropionate, parenterally administered dexamethasone, aerosolized propellant [control]), and respiratory frequency and subjective assessment of respiratory effect were determined twice daily. Maximal change in pleural pressure (delta-Pplmax), pulmonary resistance (RL), and dynamic compliance (Cdyn) was determined on days 0, 7, 10, 14, and 21. Results: The RL and delta Pplmax were increased, and Cdyn was decreased in all horses in response to natural challenge. Beclomethasone reduced RL on day 10, reduced delta Pplmax on days 14 and 21 and increased Cdyn on day 14. Dexamethasone reduced RL and delta Pplmax on days 10, 14, and 21 and increased Cdyn on days 10 and 14. Respiratory effort (subjective assessment) improved after 2 and 3 days of beclomethasone and dexamethasone administration but rebounded to pretreatment values 1 and 3 days after discontinuation of drugs. Conclusions: Pulmonary function testing responses and clinical signs of airway obstruction were improved by administration of beclomethasone. The magnitude of response to aerosolized beclomethasone generally was less marked than the response to parenterally administered dexamethasone. Higher or more frequent dosing of aerosolized beclomethasone may be necessary to achieve the anti-inflammatory response to parenterally administered dexamethasone.
Publication Date: 1998-08-26 PubMed ID: 9706210
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Randomized Controlled Trial

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the effect of aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone respectively on horses with recurrent airway obstruction or ‘heaves’. The study indicates that both methods improved symptoms and pulmonary function of the horses, but parenteral administration seemed to have a more pronounced effect.

Research Methodology

  • Six horses with inducible and reversible ‘heaves’ were part of this study.
  • ‘Heaves’ or episodes of recurrent airway obstruction were induced in these horses by exposure to moldy hay and straw for 7 days.
  • Horses were assigned to various treatment groups – those receiving aerosolized beclomethasone dipropionate, some that were administered dexamethasone parenterally, and a control group receiving aerosolized propellant.
  • Daily evaluations included measuring respiratory frequency and a subjective assessment of respiratory effect. Additionally, changes in pleural pressure (∆Pplmax), pulmonary resistance (RL), and dynamic compliance (Cdyn) were mapped over days 0, 7, 10, 14, and 21 of the study.

Research Findings

  • All horses exhibited increased pulmonary resistance and pleural pressure, and decreased dynamic compliance in response to the challenge of exposure to moldy hay and straw.
  • Administration of beclomethasone reduced pulmonary resistance by day 10, decreased change in pleural pressure on days 14 and 21, and brought about an increase in dynamic compliance on day 14.
  • For horses treated with dexamethasone, pulmonary resistance and pleural pressure were reduced, while dynamic compliance was increased on days 10, 14, and 21.
  • From subjective evaluations, an improvement in respiratory effort was noted within 2 and 3 days of administering beclomethasone and dexamethasone. However, these improvements regressed to initial values within 1 and 3 days, respectively, after discontinuing the drugs.

Research Conclusion

  • Pulmonary function was improved in horses suffering from recurrent airway obstruction by using both beclomethasone and dexamethasone.
  • The study found that the response to aerosolized beclomethasone was generally less marked than that achieved with the parenterally administered dexamethasone. For this reason, the researchers concluded that it might be beneficial to increase the dose or frequency of aerosolized beclomethasone to match the anti-inflammatory response observed in the use of parenterally administered dexamethasone.

Cite This Article

APA
Rush BR, Raub ES, Rhoads WS, Flaminio MJ, Matson CJ, Hakala JE, Gillespie JR. (1998). Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am J Vet Res, 59(8), 1039-1043.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 59
Issue: 8
Pages: 1039-1043

Researcher Affiliations

Rush, B R
  • Department of Clinical Services, College of Veterinary Medicine, Kansas State University, Manhattan 66506-5606, USA.
Raub, E S
    Rhoads, W S
      Flaminio, M J
        Matson, C J
          Hakala, J E
            Gillespie, J R

              MeSH Terms

              • Administration, Inhalation
              • Aerosols
              • Airway Obstruction / drug therapy
              • Airway Obstruction / physiopathology
              • Airway Obstruction / veterinary
              • Animal Feed
              • Animals
              • Anti-Inflammatory Agents / administration & dosage
              • Anti-Inflammatory Agents / therapeutic use
              • Beclomethasone / administration & dosage
              • Beclomethasone / therapeutic use
              • Cross-Over Studies
              • Dexamethasone / administration & dosage
              • Dexamethasone / therapeutic use
              • Double-Blind Method
              • Female
              • Food Microbiology
              • Horse Diseases / drug therapy
              • Horse Diseases / etiology
              • Horse Diseases / physiopathology
              • Horses
              • Injections, Intravenous
              • Male
              • Recurrence
              • Respiration / drug effects
              • Respiration / physiology
              • Respiratory Function Tests / veterinary

              Citations

              This article has been cited 12 times.
              1. Westermann CM, de Bie AG, Olave C, de Grauw JC, Teske E, Couetil LL. Effect of Lavage Solution Type on Bronchoalveolar Lavage Fluid Cytology in Clinically Healthy Horses.. Animals (Basel) 2023 Aug 15;13(16).
                doi: 10.3390/ani13162637pubmed: 37627428google scholar: lookup
              2. Morini M, Gobbo F, Rinnovati R, Romagnoli N, Peli A, Massarenti C, Spadari A, Pietra M. Bronchoalveolar Lavage Cytology in Severe Equine Asthma: Cytocentrifugated versus Sediment Smear Preparations.. Vet Sci 2023 Aug 16;10(8).
                doi: 10.3390/vetsci10080527pubmed: 37624314google scholar: lookup
              3. Rutledge JJ, Paegelow J, Ritchey J, Singh A, Rizzi T, Murray C, Gilliam L, Crisman E, Williams NJ, Holbrook TC. Nebulized glycosylated caffeic acid phenylether ester attenuation of environmental particulate-induced airway inflammation in horses.. Front Vet Sci 2022;9:958567.
                doi: 10.3389/fvets.2022.958567pubmed: 36406065google scholar: lookup
              4. Klier J, Fuchs S, Winter G, Gehlen H. Inhalative Nanoparticulate CpG Immunotherapy in Severe Equine Asthma: An Innovative Therapeutic Concept and Potential Animal Model for Human Asthma Treatment.. Animals (Basel) 2022 Aug 16;12(16).
                doi: 10.3390/ani12162087pubmed: 36009677google scholar: lookup
              5. Mainguy-Seers S, Lavoie JP. Glucocorticoid treatment in horses with asthma: A narrative review.. J Vet Intern Med 2021 Jul;35(4):2045-2057.
                doi: 10.1111/jvim.16189pubmed: 34085342google scholar: lookup
              6. Morini M, Peli A, Rinnovati R, Magazzù G, Romagnoli N, Spadari A, Pietra M. Immunohistochemical Expression of Neurokinin-A and Interleukin-8 in the Bronchial Epithelium of Horses with Severe Equine Asthma Syndrome during Asymptomatic, Exacerbation, and Remission Phase.. Animals (Basel) 2021 May 12;11(5).
                doi: 10.3390/ani11051376pubmed: 34066204google scholar: lookup
              7. Pirie RS, Mueller HW, Engel O, Albrecht B, von Salis-Soglio M. Inhaled ciclesonide is efficacious and well tolerated in the treatment of severe equine asthma in a large prospective European clinical trial.. Equine Vet J 2021 Nov;53(6):1094-1104.
                doi: 10.1111/evj.13419pubmed: 33403727google scholar: lookup
              8. Klier J, Bartl C, Geuder S, Geh KJ, Reese S, Goehring LS, Winter G, Gehlen H. Immunomodulatory asthma therapy in the equine animal model: A dose-response study and evaluation of a long-term effect.. Immun Inflamm Dis 2019 Sep;7(3):130-149.
                doi: 10.1002/iid3.252pubmed: 31141308google scholar: lookup
              9. Lavoie JP, Leclere M, Rodrigues N, Lemos KR, Bourzac C, Lefebvre-Lavoie J, Beauchamp G, Albrecht B. Efficacy of inhaled budesonide for the treatment of severe equine asthma.. Equine Vet J 2019 May;51(3):401-407.
                doi: 10.1111/evj.13018pubmed: 30203854google scholar: lookup
              10. Mainguy-Seers S, Picotte K, Lavoie JP. Efficacy of tamoxifen for the treatment of severe equine asthma.. J Vet Intern Med 2018 Sep;32(5):1748-1753.
                doi: 10.1111/jvim.15289pubmed: 30084157google scholar: lookup
              11. Herteman N, Vargas A, Lavoie JP. Characterization of Circulating Low-Density Neutrophils Intrinsic Properties in Healthy and Asthmatic Horses.. Sci Rep 2017 Aug 10;7(1):7743.
                doi: 10.1038/s41598-017-08089-5pubmed: 28798364google scholar: lookup
              12. Ivester KM, Couëtil LL, Zimmerman NJ. Investigating the link between particulate exposure and airway inflammation in the horse.. J Vet Intern Med 2014 Nov-Dec;28(6):1653-65.
                doi: 10.1111/jvim.12458pubmed: 25273818google scholar: lookup